Gilead's cell therapy business Kite cuts 7% of workforce
Gilead’s cell therapy subsidiary Kite Pharma is letting go of roughly 300 employees, or about 7% of the unit’s staff.
“We are taking measures to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
